Antares Pharma, Inc. (ATRS)

[jab91252]

Antares '631 patent, claim 1 states:

What is claimed is:
1. A hazardous agent injection system, the hazardous agent injection system comprising:
methotrexate in an amount of from about 0.02 ml to about 4.0 ml and at a concentration of from about 7.5 mg/ml to about 150 mg/ml;
a needle-assisted jet injector, the needle-assisted jet injector comprising:
a container configured to contain the methotrexate;


Antares filed there lawsuit v Medac to protect the shareholders interest. Medac response was to file their own lawsuit (see definition of "patent trolls". Medac's filing, imo, will be dismissed.